These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22350402)

  • 21. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
    Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [THE PATHOGENIC POTENTIAL OF MORAXELLA CATARRHALIS AND STAPHYLOCOCCUS EPIDERMIDIS UNDER INFLAMMATORY PROCESSES OF UPPER RESPIRATORY TRACTS].
    Kraeva LA; Burgasova OA; Kunilova ES; Petrova IS; Tseneva GY; Bespalova GL
    Klin Lab Diagn; 2015 Nov; 60(11):58-61. PubMed ID: 26999868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance Programme.
    Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
    J Antimicrob Chemother; 2003 Dec; 52(6):925-30. PubMed ID: 14585864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a ten-minute chromogenic substrate test for identification of pathogenic Neisseria species and Branhamella catarrhalis.
    Janda WM; Sobieski V
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):25-9. PubMed ID: 3132371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of community-acquired respiratory tract pathogens in the UK during 2002/3 determined locally and centrally by BSAC methods.
    Morrissey I; Robbins M; Viljoen L; Brown DF
    J Antimicrob Chemother; 2005 Feb; 55(2):200-8. PubMed ID: 15649996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 27. [Moraxella (Branhamella) catarrhalis: its isolation in the respiratory secretions of adult patients].
    Ferrer Marcellés A; Martínez Ojeda E; Falcó Ferrer V; de la Torre Tejedor E; González Fuente T
    An Med Interna; 1997 Nov; 14(11):554-8. PubMed ID: 9445580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterisation of Branhamella catarrhalis and differentiation from Neisseria species in a diagnostic laboratory.
    Ahmad F; Young H; McLeod DT; Croughan MJ; Calder MA
    J Clin Pathol; 1987 Nov; 40(11):1369-73. PubMed ID: 2826546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moraxella catarrhalis M35 is a general porin that is important for growth under nutrient-limiting conditions and in the nasopharynges of mice.
    Easton DM; Maier E; Benz R; Foxwell AR; Cripps AW; Kyd JM
    J Bacteriol; 2008 Dec; 190(24):7994-8002. PubMed ID: 18931134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative detection of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in lower respiratory tract samples by real-time PCR.
    Kais M; Spindler C; Kalin M; Ortqvist A; Giske CG
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):169-78. PubMed ID: 16626914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic resistance patterns of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a prospective study in Murcia, Spain, 1983-1992.
    Gómez J; Ruiz-Gómez J; Hernández-Cardona JL; Núñez ML; Canteras M; Valdés M
    Chemotherapy; 1994; 40(5):299-303. PubMed ID: 7956452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and emerging resistance of Moraxella catarrhalis in lower respiratory tract infections in Karachi.
    Abdullah FE; Ahuja KR; Kumar H
    J Pak Med Assoc; 2013 Nov; 63(11):1342-4. PubMed ID: 24392515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moraxella catarrhalis as a respiratory pathogen.
    Gupta N; Arora S; Kundra S
    Indian J Pathol Microbiol; 2011; 54(4):769-71. PubMed ID: 22234107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children.
    Ahmed A; Broides A; Givon-Lavi N; Peled N; Dagan R; Greenberg D
    Pediatr Infect Dis J; 2008 May; 27(5):459-61. PubMed ID: 18360302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supplement peptone agar--a simple carbohydrate degradation plate medium for the identification of Neisseria species.
    Stoakes L; Schieven B; Hussain Z; Lannigan R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):131-6. PubMed ID: 3115001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance patterns among respiratory pathogens at a German university children's hospital over a period of 10 years.
    Arri SJ; Fluegge K; Mueller U; Berner R
    Eur J Pediatr; 2006 Jan; 165(1):9-13. PubMed ID: 16133241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
    J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective study of intrafamilial transmission and antimicrobial susceptibility of Moraxella catarrhalis.
    Masaki H; Qin L; Zhou Z; Onizuka T; Watanabe K; Hu B; Watanabe H
    Microbiol Immunol; 2011 Sep; 55(9):599-604. PubMed ID: 21668485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1992; 38(1):7-13. PubMed ID: 1618006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.